SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 2185281

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 2185281

Radiolabeling Service Market Report: Trends, Forecast and Competitive Analysis to 2035

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 4850
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 6700
PDF, Excel & 1 Year Online Access (Corporate License)
USD 8850
PDF, Excel & 1 Year Online Access (Global License)
USD 10000

Add to Cart

Radiolabeling Service Market

The future of the global radiolabeling service market looks promising with opportunities in the pharmacokinetics and pharmacodynamics, and medical markets. The global radiolabeling service market is expected to reach an estimated $15 billion by 2035 from $8 billion in 2027 with a CAGR of 18.4% from 2027 to 2035. The major drivers for this market are the increasing demand for precise drug behavior analysis in clinical trials and the growing need for radiolabeled compounds in drug development processes.

  • Lucintel forecasts that, within the type category, C-14 is expected to witness higher growth over the forecast period due to increasing cases of carbon-14 labeling in drug metabolism studies.
  • Within the application category, pharmacokinetics and pharmacodynamics are expected to witness higher growth over the forecast period due to growing out-sourcing in pharmaceutical research.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to growing out-sourcing in pharmaceutical research.

Emerging Trends in Radiolabeling Service Market

Between 2025 and 2027, the radiolabeling service market will transition from a primarily project-based model to a fully integrated discovery, clinical, and manufacturing services model. Growth is expected as the demand for radiopharmaceutical services grows, coupled with increasing regulatory scrutiny and outsourcing from manufacturers. According to Lucintel, the market will be dominated by capacity, compliance, and specialized talent.

  • Automation: By 2025, the majority of contract research organizations (CROs) had automated both synthesis and quality control workflows. Leading manufacturers of PET tracers offer systems that can complete synthesis in less than two hours. In the next 3 to 5 years, automation will improve batch consistency and enable larger clinical demands.
  • Theranostics: The focus of clinical investment has-and will continue to-shift to the development of paired therapeutic and diagnostic radionuclides. There were more than 100 labeled radiopharmaceuticals reported in industry pipelines in 2025. This will create a greater demand for labeling, dosimetry, and release testing. This platform will become a steady stream of service revenue once fully developed targeted oncology programs begin.
  • Supply-chain Diversification: Long lead times for short lived isotopes have generated a trend toward regional production, backup suppliers, and flexible logistics. The 2025 medical isotope initiatives in the European Union focused on strengthening domestic resilience.
  • Regulatory Standardization: Increasingly, sponsors are requiring documented chain of custody, validated methods, and GMP aligned records. 2025 saw an increase in FDA guidance that outlines expectations for the development of radiopharmaceuticals. Standardized evidence will become a differentiator among specialist service providers and non-specialist laboratories.
  • Personalized Medicine: 2025 saw personalized radiopharmaceutical trials begin to represent a larger share of early pipelines. In this area, fragments and peptides show the most promise. The development of radiopharmaceuticals that can be tailored to individual patients is gaining steam. The combination of considerable flexibility in the small batch and quick analytics will allow some service providers to win a large portion of the business that larger high volume competitors cannot address.

In the coming years, the focus will shift away from how much of a particular isotope is available to who has the best execution. In this scenario, the customer will opt to work with service providers that incorporate discovery chemistry and GMP manufacturing along with validated analytics and reliable logistics. Additional capacity will be of great value to meet the increased demand, but pricing will continue to be firm due to workforce shortages and volatile isotopes. Sponsors will most likely opt to work with service providers that offer multiple services to address various needs, as consolidation is likely.

Recent Developments in the Radiolabeling Service Market

The current trajectory of the radiolabeling service market is indicative of a shift away from niche, specialist research support towards regulated, fully integrated radiopharmaceutical manufacturing supported by end-to-end services. Lucintel anticipates that this transition will occur in the 2025-2027 timeframe due to the maturation of radioligand pipelines, tighter isotope supplies, and outsourcing of radiopharmaceutical development by pharmaceutical firms. According to Lucintel, vendors with GMP capacity, validated analytics, and reliable logistics will capture the majority of the growth.

  • Radioligand Therapy Expansion: On March 28, 2025, the FDA extended the indication for Pluvicto to include PSMA-positive metastatic castration-resistant prostate cancer, thereby creating demand for radiolabeling, release testing, and dose preparation. This will increase the contract provider's recurring commercial workload for the next three to five years.
  • Investments in GMP Capacity: In 2025, ITM announced the upcoming construction of additional capacity for the clinical and commercial radiopharmaceuticals that support ITM's targeted radionuclide therapy. Increased capacity will become more important to sponsors, as they are increasingly requiring audited and scalable radiolabeling services, as opposed to laboratory support.
  • Formation of Isotope Supply Partnerships: In 2025, the major vendors of radiopharmaceuticals continued to secure long-term, multiple-year supply agreements for actinium-225 and lutetium-177 isotopes. These agreements will fundamentally affect the choice of vendors, as radiolabeling companies must be able to provide isotopes with short lead times and maintain backup sourcing in order to be selected for vendor contracts.
  • Consolidation of Contract Development: The major CDMOs continued focused radiosynthesis, biologics development, and GMP manufacturing partnerships and acquisitions in 2025. This will result in a reduced number of vendors, with a focus on vendors that are able to perform radiochemistry work from the feasibility stage through phase 3 and into the commercial manufacturing stage.
  • Embracing Automation in Radiochemistry: The introduction of more sophisticated cassette-based synthesis systems capable of producing clinical batches with touch labor reduction at the supplier level in 2025 signals the start of a five-year period of increasing automation of batch synthesis which will affect margins and compliance through increased batch uniformity and decreased radiation exposure, and will also provide the capability for decentralized production.

Radiolabeling services are shifting from being project-based to being capacity-based, which signals an infiux of customers. The first movers will win the professional services contracts. Early clinical need is what will drive companies to build their capacity. What matters the most, is how stable a company's services are. That is what differentiates themselves in the isotope security, automated, and regulated field. Small labs will be needed for specialized isotope types and early stage research.

Strategic Growth Opportunities in the Radiolabeling Service Market

The service of radiolabeling is moving from specialized production of tracers to full integration of developmental services. There are growing market opportunities during the forecast period of 2024-2026, stemming from growing radiopharmaceutical pipelines, increasing demands of dosimetry, and gaps in the capacity of nuclear medicine. Lucintel has identified growth in the outsourcing of GMP production, isotope logistics, and advanced services.

  • Clinical-trial Radiolabeling: First in Human (FiH) studies require tailored and flexible services. In January 2025, the FDA reported 16 radiopharmaceutical approvals in the last two years, demonstrating the strength of the pipeline. Outsourcing of hot cells will continue to gain traction as biotech choose to avoid costly and underutilized in-house hot cells.
  • Support of Targeted Alpha Therapy: Alpha emitters have short half-lives and require specialized transportation. In February 2025, the IAEA reported more than 4000 Nuclear Medicine facilities. Providers that offer alpha therapy can capture a greater percentage of the market as targeted alpha therapy moves to broader based clinical studies.
  • Regional Isotope Networks: Creating local production and emergency backup supplies reduces supply risk. In March 2025, the European Commission dedicated €100 million to improve the security of medical radioisotopes. Regional radiolabeling hubs will gain sponsor contracts for reliable supply and reduced exposure to supply chain.
  • Digital Dosimetry Services: Software automation to calculate doses and digitize batch records reduces regulatory review time. In April 2025, the FDA's oncology center reported more than 30 active radiopharmaceutical development programs. Integrated software will influence vendor selection as regulatory agencies demand reproducible patient-specific exposure data.
  • Personalized Companion Diagnostics: Radiolabeled imaging agents can be used to select patients prior to administering a costly therapy. At its annual meeting in May 2025, over 200 exhibitors were reported by the Society of Nuclear Medicine and Molecular Imaging, showing a boom in commercial activity. Imaging service firms that integrate biomarker services and provide an image production service will gain long-term pharmaceutical business.

In the upcoming five years, the radiolabeling service market winners will integrate isotope, validated chemistry, and compliant data with their responsive clinical services. The demand for their services will move beyond oncology and into maturing cardiology and neurology, as well as targeted alpha therapy. The early stage regional capacity and flexible contracting services will allow providers to capture the outsourcing from sponsors. Operators with more limited services face margin risk from supply volatility and demand imbalance.

Radiolabeling Service Market Drivers and Challenges

Growth of radiolabeling service market is caused by innovation, advancement in precision medicine, capital investment, sustainability, and improved regulations. Research, production, pricing, and service availability will be impacted by these components. Lucintel noted that the market is becoming more advanced and competitive and that, in the long run, innovation and compliance will decide which companies will be successful.

The factors responsible for driving this market include:

  • The Use of Precision Medicine: The demand for radiolabeled molecules will continue to grow due to an increase in targeted therapies and diagnostic imaging in oncology, neurology, and cardiology. In its March 2025 report, the FDA noted over 30 approved radiopharmaceuticals in the US. In the next 3-5 years, the growing number of personalized treatments will drive pharmaceutical companies to outsource their radiolabeling to specialized companies.
  • New Technology: Innovations in automation, microfluidics, artificial intelligence, and digital quality systems will enhance accuracy, consistency, automation, and interactions for real-time control for radiolabeling. As early as June 2025, research laboratories adopted automated systems to simplify and speed up multi-step radiochemistry in under an hour. These innovations will shorten lab times and increase market availability, especially for advanced isotopes.
  • Regulatory Support: Clear pathways for radiopharmaceutical development inspire investment in contract research and manufacturing services. The 2025 revision to global guidelines continued to place emphasis on validated processes, sterility, traceability, and compliance to Good Manufacturing Practices. In the next 3-5 years, regulatory convergence will allow service providers to better support multinational trials and help reduce the uncertainty and the length of time required for approval by the pharmaceutical and biotechnology sectors.
  • Product Innovation: The growing availability of new radioligand therapies and theranostic platforms as well as new isotope combinations expand the potential for radiolabeling services. In 2025, clinical developers continued to progress more than 10 radiopharmaceutical programs based on new therapeutic isotopes. This will stimulate demand for custom labeling, method development, and stability assays in both traditional and new therapeutic areas.
  • Manufacturing Efficiency: Centralized manufacturing, improved isotope logistics, and standardized radiolabeling processes enable greater consistency and less waste in batch production. Several laboratories reported regular, high-throughput production of radiolabeled compounds in 2025. In the next 3-5 years, improvements will enable service providers to address challenges posed by isotope half-lives, improve utilization and cost-effectiveness, and offer reliable services to a dispersed clientele.

The challenges facing this market include:

  • Short Isotope Half-Lives: Rapidly decaying radioisotopes pose challenges for both timely procurement, quality control, and delivery as well as for the downstream steps of the radiopharmaceutical process. Many unstable fluorine-18 based radiopharmaceuticals have a half-life of approximately 110 minutes. This will foster trends of production of radiopharmaceuticals closer to where they will be used, automation, coordinated logistics, and a reliable supplier network.
  • High Compliance Costs: Radiolabeling providers must develop all of the necessary processes, including radiation protection, maintaining a sterile environment, and validated equipment, as well as hiring personnel. Documentation is a large part of the process. Along with that, regulated facilities in October 2025 continued to operate with multiple quality requirements under one roof. In the next three to five years, compliance costs may become a burden for smaller radiolabeling service providers, leading to consolidations of the industry and allowing companies to outsource radiolabeling services.
  • Isotope Supply Constraints: There are limited medical isotopes due to a number of issues including difficulty in transport, a shortage of supplies in different regions, and geopolitical issues. In July 2025, global healthcare services worked diligently to secure the supply of molybdenum-99. This will create price spikes and delays of studies while other services invest in alternative isotopes, domestic production, isotope recycling, and long-term isotope supply contracts.

The radiolabeling service market will experience growth because of the increasing demand for outsourced radiolabeling due to the growth of radiopharmaceuticals and precision medicine. Manufacturing improvements and regulations will lead to easier, more advanced radiolabeling services in the future. However, isotope supply constraints, cost of compliance, and short isotope half-lives will increase the complexities of an already difficult process. Services that automate, offer flexible support, validated processes, and reliable isotope supply will dominate the field. Until scientific breakthroughs for radiolabeling services are realized, partnerships and new infrastructural investments will remain the only way to begin developing affordable radiolabeling services for research and precision therapeutic manufacturing and development.

List of Radiolabeling Service Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies radiolabeling service market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radiolabeling service market companies profiled in this report include-

  • Charles River
  • Eurofins Scientific
  • PerkinElmer
  • Sekisui Medical
  • Eckert & Ziegler
  • LabCorp
  • Xenotech (BioIVT)
  • Quotient Sciences
  • Gifford Bioscience
  • ITM Radiopharma

Radiolabeling Service Market by Segment

The study includes a forecast for the global radiolabeling service market by type, application, and region.

Radiolabeling Service Market by Type [Value ($B) from 2019 to 2035]:

  • C-14
  • H-3
  • I-125
  • Others

Radiolabeling Service Market by Application [Value ($B) from 2019 to 2035]:

  • Pharmacokinetics and Pharmacodynamics
  • Medical
  • Others

Radiolabeling Service Market by Region [Value ($B) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Radiolabeling Service Market

With 2025-2027 a key period as radiopharmaceutical developers advance their late-stage pipelines, radiolabeling services become more crucial for manufacturing and clinical supply. Lucintel forecasts that properly executed procedures will involve validated analytical systems, compliant isotope handling, and contract manufacturing capacity across major pharmaceutical markets.

  • United States: Market activity: Expansion of Eli Lilly's $3.7 billion manufacturing investment committed to radioligand production in Indianapolis includes a new radioligand production facility announced in May of 2024, and FDA's March of 2025 expansion of the eligible patient population for Pluvicto establishes demand for GMP radiolabeling, batch release, dosimetry, and clinical trial support. This demand will continue for the next 3 to 5 years.
  • China: Domestic isotope and radiopharmaceutical production: China National Nuclear Corporation (CNNC) and Pharmaceutical partners continued to develop regional production and distribution of radiopharmaceuticals. Additionally, the China NMPA approved radiopharmaceuticals and the combination of regulatory drugs and local supply will create demand for isotope procurement, labeling, and quality and assurance testing of products for use by hospitals.
  • Germany: Manufacturing and technology expansion: Eckert & Ziegler constructed more radiopharmaceutical manufacturing capacity, which was operational in 2025, and continued marketing of the automated radiolabeling synthesis system for hospital and contract manufacturing use. This will further enhance Germany's radiolabeling capabilities and generate demand for services and equipment.
  • India: Public-sector capacity building: The Department of Atomic Energy and BRIT improved radiopharmaceutical services by adding and upgrading isotope facilities, while in 2025, AERB reported more than 400 licensed nuclear medicine institutions. Broader clinical uptake will require radiolabeling services as well as ancillary services for logistics, testing and decentralized manufacturing.
  • Japan: Product and partnership development: Novartis launched Pluvicto for use in Japan in 2024, while Japanese hospitals continued to set up targeted radioligand therapy in 2025. The installation of targeted radioligand therapy will result in a demand for compliant packaging, patient-specific preparation, radiation safety, and specialized distribution.

Features of the Global Radiolabeling Service Market

  • Market Size Estimates: radiolabeling service market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: radiolabeling service market size by type, application, and region in terms of value ($B).
  • Regional Analysis: radiolabeling service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the radiolabeling service market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radiolabeling service market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the radiolabeling service market by type (C-14, H-3, I-125, and others), application (pharmacokinetics and pharmacodynamics, medical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Radiolabeling Service Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 C-14: Trends and Forecast (2019-2035)
  • 4.4 H-3: Trends and Forecast (2019-2035)
  • 4.5 I-125: Trends and Forecast (2019-2035)
  • 4.6 Others: Trends and Forecast (2019-2035)

5. Global Radiolabeling Service Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Pharmacokinetics and Pharmacodynamics: Trends and Forecast (2019-2035)
  • 5.4 Medical: Trends and Forecast (2019-2035)
  • 5.5 Others: Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Radiolabeling Service Market by Region

7. North American Radiolabeling Service Market

  • 7.1 Overview
  • 7.2 North American Radiolabeling Service Market by Type
  • 7.3 North American Radiolabeling Service Market by Application
  • 7.4 United States Radiolabeling Service Market
  • 7.5 Mexican Radiolabeling Service Market
  • 7.6 Canadian Radiolabeling Service Market

8. European Radiolabeling Service Market

  • 8.1 Overview
  • 8.2 European Radiolabeling Service Market by Type
  • 8.3 European Radiolabeling Service Market by Application
  • 8.4 German Radiolabeling Service Market
  • 8.5 French Radiolabeling Service Market
  • 8.6 Spanish Radiolabeling Service Market
  • 8.7 Italian Radiolabeling Service Market
  • 8.8 United Kingdom Radiolabeling Service Market

9. APAC Radiolabeling Service Market

  • 9.1 Overview
  • 9.2 APAC Radiolabeling Service Market by Type
  • 9.3 APAC Radiolabeling Service Market by Application
  • 9.4 Japanese Radiolabeling Service Market
  • 9.5 Indian Radiolabeling Service Market
  • 9.6 Chinese Radiolabeling Service Market
  • 9.7 South Korean Radiolabeling Service Market
  • 9.8 Indonesian Radiolabeling Service Market

10. ROW Radiolabeling Service Market

  • 10.1 Overview
  • 10.2 ROW Radiolabeling Service Market by Type
  • 10.3 ROW Radiolabeling Service Market by Application
  • 10.4 Middle Eastern Radiolabeling Service Market
  • 10.5 South American Radiolabeling Service Market
  • 10.6 African Radiolabeling Service Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Radiolabeling Service Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Charles River
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Eurofins Scientific
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 PerkinElmer
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Sekisui Medical
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Eckert & Ziegler
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 LabCorp
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Xenotech (Bioivt)
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Quotient Sciences
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Gifford Bioscience
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 ITM Radiopharma
    • Company Overview
    • Radiolabeling Service Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Radiolabeling Service Market
  • Figure 2.1: Usage of Radiolabeling Service Market
  • Figure 2.2: Classification of the Global Radiolabeling Service Market
  • Figure 2.3: Supply Chain of the Global Radiolabeling Service Market
  • Figure 3.1: Driver and Challenges of the Radiolabeling Service Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Radiolabeling Service Market by Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global Radiolabeling Service Market ($B) by Type
  • Figure 4.3: Forecast for the Global Radiolabeling Service Market ($B) by Type
  • Figure 4.4: Trends and Forecast for C-14 in the Global Radiolabeling Service Market (2019-2035)
  • Figure 4.5: Trends and Forecast for H-3 in the Global Radiolabeling Service Market (2019-2035)
  • Figure 4.6: Trends and Forecast for I-125 in the Global Radiolabeling Service Market (2019-2035)
  • Figure 4.7: Trends and Forecast for Others in the Global Radiolabeling Service Market (2019-2035)
  • Figure 5.1: Global Radiolabeling Service Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global Radiolabeling Service Market ($B) by Application
  • Figure 5.3: Forecast for the Global Radiolabeling Service Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Pharmacokinetics and Pharmacodynamics in the Global Radiolabeling Service Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Medical in the Global Radiolabeling Service Market (2019-2035)
  • Figure 5.6: Trends and Forecast for Others in the Global Radiolabeling Service Market (2019-2035)
  • Figure 6.1: Trends of the Global Radiolabeling Service Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global Radiolabeling Service Market ($B) by Region (2027-2035)
  • Figure 7.1: North American Radiolabeling Service Market by Type in 2019, 2026, and 2035
  • Figure 7.2: Trends of the North American Radiolabeling Service Market ($B) by Type (2019-2026)
  • Figure 7.3: Forecast for the North American Radiolabeling Service Market ($B) by Type (2027-2035)
  • Figure 7.4: North American Radiolabeling Service Market by Application in 2019, 2026, and 2035
  • Figure 7.5: Trends of the North American Radiolabeling Service Market ($B) by Application (2019-2026)
  • Figure 7.6: Forecast for the North American Radiolabeling Service Market ($B) by Application (2027-2035)
  • Figure 7.7: Trends and Forecast for the United States Radiolabeling Service Market ($B) (2019-2035)
  • Figure 7.8: Trends and Forecast for the Mexican Radiolabeling Service Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Canadian Radiolabeling Service Market ($B) (2019-2035)
  • Figure 8.1: European Radiolabeling Service Market by Type in 2019, 2026, and 2035
  • Figure 8.2: Trends of the European Radiolabeling Service Market ($B) by Type (2019-2026)
  • Figure 8.3: Forecast for the European Radiolabeling Service Market ($B) by Type (2027-2035)
  • Figure 8.4: European Radiolabeling Service Market by Application in 2019, 2026, and 2035
  • Figure 8.5: Trends of the European Radiolabeling Service Market ($B) by Application (2019-2026)
  • Figure 8.6: Forecast for the European Radiolabeling Service Market ($B) by Application (2027-2035)
  • Figure 8.7: Trends and Forecast for the German Radiolabeling Service Market ($B) (2019-2035)
  • Figure 8.8: Trends and Forecast for the French Radiolabeling Service Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the Spanish Radiolabeling Service Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Italian Radiolabeling Service Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the United Kingdom Radiolabeling Service Market ($B) (2019-2035)
  • Figure 9.1: APAC Radiolabeling Service Market by Type in 2019, 2026, and 2035
  • Figure 9.2: Trends of the APAC Radiolabeling Service Market ($B) by Type (2019-2026)
  • Figure 9.3: Forecast for the APAC Radiolabeling Service Market ($B) by Type (2027-2035)
  • Figure 9.4: APAC Radiolabeling Service Market by Application in 2019, 2026, and 2035
  • Figure 9.5: Trends of the APAC Radiolabeling Service Market ($B) by Application (2019-2026)
  • Figure 9.6: Forecast for the APAC Radiolabeling Service Market ($B) by Application (2027-2035)
  • Figure 9.7: Trends and Forecast for the Japanese Radiolabeling Service Market ($B) (2019-2035)
  • Figure 9.8: Trends and Forecast for the Indian Radiolabeling Service Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Chinese Radiolabeling Service Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the South Korean Radiolabeling Service Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the Indonesian Radiolabeling Service Market ($B) (2019-2035)
  • Figure 10.1: ROW Radiolabeling Service Market by Type in 2019, 2026, and 2035
  • Figure 10.2: Trends of the ROW Radiolabeling Service Market ($B) by Type (2019-2026)
  • Figure 10.3: Forecast for the ROW Radiolabeling Service Market ($B) by Type (2027-2035)
  • Figure 10.4: ROW Radiolabeling Service Market by Application in 2019, 2026, and 2035
  • Figure 10.5: Trends of the ROW Radiolabeling Service Market ($B) by Application (2019-2026)
  • Figure 10.6: Forecast for the ROW Radiolabeling Service Market ($B) by Application (2027-2035)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Radiolabeling Service Market ($B) (2019-2035)
  • Figure 10.8: Trends and Forecast for the South American Radiolabeling Service Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the African Radiolabeling Service Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Radiolabeling Service Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Radiolabeling Service Market (2026)
  • Figure 12.1: Growth Opportunities for the Global Radiolabeling Service Market by Type
  • Figure 12.2: Growth Opportunities for the Global Radiolabeling Service Market by Application
  • Figure 12.3: Growth Opportunities for the Global Radiolabeling Service Market by Region
  • Figure 12.4: Emerging Trends in the Global Radiolabeling Service Market

List of Tables

  • Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Radiolabeling Service Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Radiolabeling Service Market by Region
  • Table 1.3: Global Radiolabeling Service Market Parameters and Attributes
  • Table 3.1: Trends of the Global Radiolabeling Service Market (2019-2026)
  • Table 3.2: Forecast for the Global Radiolabeling Service Market (2027-2035)
  • Table 4.1: Attractiveness Analysis for the Global Radiolabeling Service Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Radiolabeling Service Market (2019-2026)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Radiolabeling Service Market (2027-2035)
  • Table 4.4: Trends of C-14 in the Global Radiolabeling Service Market (2019-2026)
  • Table 4.5: Forecast for C-14 in the Global Radiolabeling Service Market (2027-2035)
  • Table 4.6: Trends of H-3 in the Global Radiolabeling Service Market (2019-2026)
  • Table 4.7: Forecast for H-3 in the Global Radiolabeling Service Market (2027-2035)
  • Table 4.8: Trends of I-125 in the Global Radiolabeling Service Market (2019-2026)
  • Table 4.9: Forecast for I-125 in the Global Radiolabeling Service Market (2027-2035)
  • Table 4.10: Trends of Others in the Global Radiolabeling Service Market (2019-2026)
  • Table 4.11: Forecast for Others in the Global Radiolabeling Service Market (2027-2035)
  • Table 5.1: Attractiveness Analysis for the Global Radiolabeling Service Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Radiolabeling Service Market (2019-2026)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Radiolabeling Service Market (2027-2035)
  • Table 5.4: Trends of Pharmacokinetics and Pharmacodynamics in the Global Radiolabeling Service Market (2019-2026)
  • Table 5.5: Forecast for Pharmacokinetics and Pharmacodynamics in the Global Radiolabeling Service Market (2027-2035)
  • Table 5.6: Trends of Medical in the Global Radiolabeling Service Market (2019-2026)
  • Table 5.7: Forecast for Medical in the Global Radiolabeling Service Market (2027-2035)
  • Table 5.8: Trends of Others in the Global Radiolabeling Service Market (2019-2026)
  • Table 5.9: Forecast for Others in the Global Radiolabeling Service Market (2027-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Radiolabeling Service Market (2019-2026)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Radiolabeling Service Market (2027-2035)
  • Table 7.1: Trends of the North American Radiolabeling Service Market (2019-2026)
  • Table 7.2: Forecast for the North American Radiolabeling Service Market (2027-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Radiolabeling Service Market (2019-2026)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Radiolabeling Service Market (2027-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Radiolabeling Service Market (2019-2026)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Radiolabeling Service Market (2027-2035)
  • Table 7.7: Trends and Forecast for the United States Radiolabeling Service Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Radiolabeling Service Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Radiolabeling Service Market (2019-2035)
  • Table 8.1: Trends of the European Radiolabeling Service Market (2019-2026)
  • Table 8.2: Forecast for the European Radiolabeling Service Market (2027-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Radiolabeling Service Market (2019-2026)
  • Table 8.4: Market Size and CAGR of Various Type in the European Radiolabeling Service Market (2027-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Radiolabeling Service Market (2019-2026)
  • Table 8.6: Market Size and CAGR of Various Application in the European Radiolabeling Service Market (2027-2035)
  • Table 8.7: Trends and Forecast for the German Radiolabeling Service Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Radiolabeling Service Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Radiolabeling Service Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Radiolabeling Service Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Radiolabeling Service Market (2019-2035)
  • Table 9.1: Trends of the APAC Radiolabeling Service Market (2019-2026)
  • Table 9.2: Forecast for the APAC Radiolabeling Service Market (2027-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Radiolabeling Service Market (2019-2026)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Radiolabeling Service Market (2027-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Radiolabeling Service Market (2019-2026)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Radiolabeling Service Market (2027-2035)
  • Table 9.7: Trends and Forecast for the Japanese Radiolabeling Service Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Radiolabeling Service Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Radiolabeling Service Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Radiolabeling Service Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Radiolabeling Service Market (2019-2035)
  • Table 10.1: Trends of the ROW Radiolabeling Service Market (2019-2026)
  • Table 10.2: Forecast for the ROW Radiolabeling Service Market (2027-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Radiolabeling Service Market (2019-2026)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Radiolabeling Service Market (2027-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Radiolabeling Service Market (2019-2026)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Radiolabeling Service Market (2027-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Radiolabeling Service Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Radiolabeling Service Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Radiolabeling Service Market (2019-2035)
  • Table 11.1: Product Mapping of Radiolabeling Service Suppliers Based on Segments
  • Table 11.2: Operational Integration of Radiolabeling Service Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Radiolabeling Service Revenue
  • Table 12.1: New Product Launches by Major Radiolabeling Service Producers (2019-2026)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Radiolabeling Service Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!